Noninvasive Measurement of Iron by Magnetic Resonance Imaging (Sbir/Sttr)

The summary for the Noninvasive Measurement of Iron by Magnetic Resonance Imaging (Sbir/Sttr) grant is detailed below. This summary states who is eligible for the grant, how much grant money will be awarded, current and past deadlines, Catalog of Federal Domestic Assistance (CFDA) numbers, and a sampling of similar government grants. Verify the accuracy of the data FederalGrants.com provides by visiting the webpage noted in the Link to Full Announcement section or by contacting the appropriate person listed as the Grant Announcement Contact. If any section is incomplete, please visit the website for the National Institutes of Health, which is the U.S. government agency offering this grant.
Noninvasive Measurement of Iron by Magnetic Resonance Imaging (Sbir/Sttr): The National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) invites Small Business Innovation Research (SBIR) and Small Business Technology Transfer (STTR) applications for support of projects that have the potential to improve the utility of magnetic resonance imaging as a method for quantitative determinations of tissue iron, especially in liver, heart and brain. A quantitative means of measuring body storage iron that would be non-invasive, safe, accurate and readily available would improve the diagnosis and management of patients with iron overload, including hereditary hemochromatosis, thalassemia major, sickle cell disease, aplastic anemia, myelodysplasia and other disorders. Magnetic resonance imaging potentially provides a useful and widely available technique for examining the three- dimensional distribution of excess iron in the body, but further research is needed to develop a way to make measurements quantitative. This Request for Application (RFA) must be read in conjunction with the
Federal Grant Title: Noninvasive Measurement of Iron by Magnetic Resonance Imaging (Sbir/Sttr)
Federal Agency Name: National Institutes of Health
Grant Categories: Health
Type of Opportunity: Discretionary
Funding Opportunity Number: RFA-DK-03-009
Type of Funding: Grant
CFDA Numbers: 93.849
CFDA Descriptions: Kidney Diseases, Urology and Hematology Research
Current Application Deadline: No deadline provided
Original Application Deadline: Feb 19, 2003
Posted Date: Oct 28, 2002
Creation Date: Mar 21, 2003
Archive Date: Mar 21, 2003
Total Program Funding:
Maximum Federal Grant Award:
Minimum Federal Grant Award:
Expected Number of Awards:
Cost Sharing or Matching: No
Applicants Eligible for this Grant
State governments County governments City or township governments Special district governments Independent school districts Public and State controlled institutions of higher education Native American tribal governments (Federally recognized) Public housing authorities/Indian housing authorities Native American tribal organizations (other than Federally recognized tribal governments) Nonprofits having a 501(c)(3) status with the IRS, other than institutions of higher education Private institutions of higher education Individuals For profit organizations other than small businesses Small businesses Others (see text field entitled "Additional Information on Eligibility" for clarification)
Link to Full Grant Announcement
Information not provided
Grant Announcement Contact
If you have any problems linking to this funding announcement, please contact the NIH OER Webmaster [email protected] NIH OER Webmaster
Similar Government Grants
Investigations on Primary Immunodeficiency Diseases (R01)
Grants for Basic Research in Glomerular Diseases (R01)
Advances in Polycystic Kidney Disease (R01)
Ancillary Studies of Kidney Disease Accessing Information from Clinical Trials, Epidemiolo...
Calcium Oxalate Stone Diseases (R01)
Research Grants for Clinical Studies of Kidney Diseases
Chronic Prostatitis Collaborative Research Network (Cpcrn)
Frequent Hemodialysis Clinical Trials
More Grants from the National Institutes of Health
HEAL Initiative: Studies to Enable Analgesic Discovery (R61/R33 - Clinical Trial Not Allow...
Technologies and Assays for Therapeutic Genome Editing INDs (U01, Clinical Trial Not Allow...
Developmental AIDS Research Center on Mental Health and HIV/AIDS (P30 Clinical Trial Optio...
AIDS Research Center on Mental Health and HIV/AIDS (P30 Clinical Trial Optional)
NIH Directors Pioneer Award Program (DP1 Clinical Trial Optional)

FederalGrants.com is not endorsed by, or affiliated with, any government agency. Copyright ©2007-2024 FederalGrants.com